Evoq Remedies
BSE: EVOQ · Trading & Distributors
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Evoq Remedies's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Evoq Remedies Limited is an Ahmedabad-based pharmaceutical company specialising in the trading and distribution of diverse pharmaceutical formulations. The firm operates as a merchant exporter and intermediary, sourcing products from domestic manufacturers for supply to local and international markets.
Business Model
The company employs a lean business model focused on supply chain management and distribution logistics rather than direct manufacturing. It generates revenue by acting as an intermediary in the pharmaceutical value chain, facilitating the trade of tablets, capsules, and other dosage forms.
Management Commentary
Management emphasises the company's role as a strategic link in the pharmaceutical supply chain, prioritising the sourcing of quality products to meet market demand.
Growth Outlook
Growth is expected to be driven by the expansion of its distribution network and the leveraging of its merchant exporter status to capture demand in international pharmaceutical markets.
Key Risks
- Supply Chain Dependency. The company relies heavily on third-party domestic manufacturers, making it vulnerable to supply disruptions or quality control issues.
- Regulatory Risk. As a pharmaceutical distributor, the company is subject to stringent and evolving health regulations in both domestic and international markets.
- Market Competition. The trading and distribution sector is highly fragmented, leading to intense price competition and potential margin compression.
- Currency Fluctuation. As a merchant exporter, the company faces exposure to foreign exchange volatility which may impact the profitability of international transactions.
Start your research today
Unlock AI insights, financials, peers and live data on Evoq Remedies and 5,000+ companies — free.
Peers · Trading & Distributors
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Evoq RemediesEVOQ | ₹4 Cr | — | — | — | -5.7% | — | — | -45.1% |
Veritas (India)VERITAS | ₹445 Cr | 8.63 | 7.06 | -24.1% | 3.9% | 1.9% | 2.7% | -55.4% |
Kothari ProductsKOTHARIPRO | ₹407 Cr | 179.58 | -12.12 | -18.3% | -5.1% | -0.2% | -2.3% | -9.8% |
Rotographics (India) LimitedRGIL | ₹404 Cr | 94.62 | 326.54 | 4987.7% | 3.0% | 12.6% | 17.2% | — |
Polo Queen Industrial and Fintech LimitedPQIF | ₹333 Cr | 141.71 | 64.71 | -5.7% | 7.0% | 1.3% | 2.5% | -79.1% |
Constronics Infra Ltd.CONSTRONIC | ₹61 Cr | — | — | — | 5.5% | — | — | -24.7% |
As of Mar 2026
Financials
Evoq Remedies
BSE: EVOQ · Trading & Distributors
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Evoq Remedies's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Evoq Remedies Limited is an Ahmedabad-based pharmaceutical company specialising in the trading and distribution of diverse pharmaceutical formulations. The firm operates as a merchant exporter and intermediary, sourcing products from domestic manufacturers for supply to local and international markets.
Business Model
The company employs a lean business model focused on supply chain management and distribution logistics rather than direct manufacturing. It generates revenue by acting as an intermediary in the pharmaceutical value chain, facilitating the trade of tablets, capsules, and other dosage forms.
Management Commentary
Management emphasises the company's role as a strategic link in the pharmaceutical supply chain, prioritising the sourcing of quality products to meet market demand.
Growth Outlook
Growth is expected to be driven by the expansion of its distribution network and the leveraging of its merchant exporter status to capture demand in international pharmaceutical markets.
Key Risks
- Supply Chain Dependency. The company relies heavily on third-party domestic manufacturers, making it vulnerable to supply disruptions or quality control issues.
- Regulatory Risk. As a pharmaceutical distributor, the company is subject to stringent and evolving health regulations in both domestic and international markets.
- Market Competition. The trading and distribution sector is highly fragmented, leading to intense price competition and potential margin compression.
- Currency Fluctuation. As a merchant exporter, the company faces exposure to foreign exchange volatility which may impact the profitability of international transactions.
Start your research today
Unlock AI insights, financials, peers and live data on Evoq Remedies and 5,000+ companies — free.
Peers · Trading & Distributors
As of Mar 2026